139 related articles for article (PubMed ID: 10982162)
1. Comparison of serum and urine assays for biochemical markers of bone resorption in postmenopausal women with and without hormone replacement therapy and in men.
Fall PM; Kennedy D; Smith JA; Seibel MJ; Raisz LG
Osteoporos Int; 2000; 11(6):481-5. PubMed ID: 10982162
[TBL] [Abstract][Full Text] [Related]
2. Markers of bone resorption--measurement in serum, plasma or urine?
Huber F; Traber L; Roth HJ; Heckel V; Schmidt-Gayk H
Clin Lab; 2003; 49(5-6):203-7. PubMed ID: 15285175
[TBL] [Abstract][Full Text] [Related]
3. The predictive value of biochemical markers of bone turnover for bone mineral density in postmenopausal Japanese women.
Chaki O; Yoshikata I; Kikuchi R; Nakayama M; Uchiyama Y; Hirahara F; Gorai I
J Bone Miner Res; 2000 Aug; 15(8):1537-44. PubMed ID: 10934652
[TBL] [Abstract][Full Text] [Related]
4. Novel serum markers of bone resorption: clinical assessment and comparison with established urinary indices.
Woitge HW; Pecherstorfer M; Li Y; Keck AV; Horn E; Ziegler R; Seibel MJ
J Bone Miner Res; 1999 May; 14(5):792-801. PubMed ID: 10320528
[TBL] [Abstract][Full Text] [Related]
5. Specific changes of urinary excretion of cross-linked N-telopeptides of type I collagen in pre- and postmenopausal women: correlation with other markers of bone turnover.
Gorai I; Taguchi Y; Chaki O; Nakayama M; Minaguchi H
Calcif Tissue Int; 1997 Apr; 60(4):317-22. PubMed ID: 9075625
[TBL] [Abstract][Full Text] [Related]
6. Bone sialoprotein is a specific biochemical marker of bone metabolism in postmenopausal women: a randomized 1-year study.
Störk S; Störk C; Angerer P; Kothny W; Schmitt P; Wehr U; von Schacky C; Rambeck W
Osteoporos Int; 2000; 11(9):790-6. PubMed ID: 11148806
[TBL] [Abstract][Full Text] [Related]
7. Circulating levels of osteoclast activating cytokines, interleukin-11 and transforming growth factor-beta2, as valuable biomarkers for the assessment of bone turnover in postmenopausal osteoporosis.
Shaarawy M; Zaki S; Sheiba M; El-Minawi AM
Clin Lab; 2003; 49(11-12):625-36. PubMed ID: 14651333
[TBL] [Abstract][Full Text] [Related]
8. The effect of hormone replacement therapy in postmenopausal women on urinary C-telopeptide and N-telopeptide of type I collagen, new markers of bone resorption.
Taga M; Uemura T; Minaguchi H
J Endocrinol Invest; 1998 Mar; 21(3):154-9. PubMed ID: 9591210
[TBL] [Abstract][Full Text] [Related]
9. Clinical evaluation of the Serum CrossLaps One Step ELISA, a new assay measuring the serum concentration of bone-derived degradation products of type I collagen C-telopeptides.
Christgau S; Rosenquist C; Alexandersen P; Bjarnason NH; Ravn P; Fledelius C; Herling C; Qvist P; Christiansen C
Clin Chem; 1998 Nov; 44(11):2290-300. PubMed ID: 9799756
[TBL] [Abstract][Full Text] [Related]
10. Differences in the capacity of several biochemical bone markers to assess high bone turnover in early menopause and response to alendronate therapy.
Fink E; Cormier C; Steinmetz P; Kindermans C; Le Bouc Y; Souberbielle JC
Osteoporos Int; 2000; 11(4):295-303. PubMed ID: 10928218
[TBL] [Abstract][Full Text] [Related]
11. Serum bone sialoprotein: a marker of bone resorption in postmenopausal osteoporosis.
Shaarawy M; Hasan M
Scand J Clin Lab Invest; 2001; 61(7):513-21. PubMed ID: 11763409
[TBL] [Abstract][Full Text] [Related]
12. An immunoassay for type I collagen alpha 1 helicoidal peptide 620-633, a new marker of bone resorption in osteoporosis.
Garnero P; Delmas PD
Bone; 2003 Jan; 32(1):20-6. PubMed ID: 12584032
[TBL] [Abstract][Full Text] [Related]
13. New biochemical markers of bone resorption in the study of postmenopausal osteoporosis.
de la Piedra C; Traba ML; Dominguez Cabrera C; Sosa Henríquez M
Clin Chim Acta; 1997 Sep; 265(2):225-34. PubMed ID: 9385464
[TBL] [Abstract][Full Text] [Related]
14. Comparison of serum and urinary C-terminal telopeptide of type I collagen in aging, menopause and osteoporosis.
Kawana K; Takahashi M; Hoshino H; Kushida K
Clin Chim Acta; 2002 Feb; 316(1-2):109-15. PubMed ID: 11750280
[TBL] [Abstract][Full Text] [Related]
15. Markers of bone turnover in postmenopausal women receiving hormone replacement therapy.
Hamwi A; Ganem AH; Grebe C; Kerschan-Schindl K; Preisinger E; Boschitsch E; Bieglmayer C
Clin Chem Lab Med; 2001 May; 39(5):414-7. PubMed ID: 11434391
[TBL] [Abstract][Full Text] [Related]
16. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis.
Garnero P; Sornay-Rendu E; Chapuy MC; Delmas PD
J Bone Miner Res; 1996 Mar; 11(3):337-49. PubMed ID: 8852944
[TBL] [Abstract][Full Text] [Related]
17. The relationship of biochemical markers of bone turnover to bone density changes in postmenopausal women: results from the Postmenopausal Estrogen/Progestin Interventions (PEPI) trial.
Marcus R; Holloway L; Wells B; Greendale G; James MK; Wasilauskas C; Kelaghan J
J Bone Miner Res; 1999 Sep; 14(9):1583-95. PubMed ID: 10469288
[TBL] [Abstract][Full Text] [Related]
18. Is skeletal responsiveness to thyroid hormone altered in primary osteoporosis or following estrogen replacement therapy?
Langdahl BL; Loft AG; Møller N; Weeke J; Eriksen EF; Mosekilde L; Charles P
J Bone Miner Res; 1997 Jan; 12(1):78-88. PubMed ID: 9240729
[TBL] [Abstract][Full Text] [Related]
19. Urinary excretion of type I collagen crosslinked N-telopeptides in healthy Japanese adults: age- and sex-related changes and reference limits.
Sone T; Miyake M; Takeda N; Fukunaga M
Bone; 1995 Oct; 17(4):335-9. PubMed ID: 8573404
[TBL] [Abstract][Full Text] [Related]
20. [Age-related and menopause-related changes of urinary excretion of C- and N-terminal cross-linked telopeptides of type I collagen and the relationships thereof with menopause-related bone loss].
Liu SP; Liao EY; Wu XP; Cao XZ; Shan PF; Su X
Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(6):371-5. PubMed ID: 16677543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]